NeoPhore

About:

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

Website: http://www.neophore.com/

Twitter/X: neophoreltd

Top Investors: Innovate UK, Bristol-Myers Squibb, Neva SGR, LIFTT, Astellas Venture Management

Description:

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.The company's small molecule therapies target genetic mechanisms in order to create neoantigen which is known to stimulate the immune system and potentially be a weak spot in a tumor cell's defense mechanisms, enabling cancer patients to get treated and achieve improved clinical outcomes.